NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes

Journal of Endocrinology

Volumn 173, Issue 3, 2002, Pages 457-464

  Mabley, J G ^a   Hasko G ^a   Liaudet, L ^a   Soriano, F ^a   Southan, G J ^a   Salzman, A L ^a   Szabo C ^a  

^a INOTEK CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; NITRIC OXIDE; OXIDIZING AGENT; PROTEIN P50; PROTEIN SUBUNIT; STREPTOZOCIN; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; GENE DISRUPTION; IMMUNOSTIMULATION; IN VITRO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FUNCTION; STREPTOZOCIN DIABETES; ANIMAL; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; MOUSE MUTANT; PANCREAS ISLET; SECRETION;

ANIMALS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DRUG ADMINISTRATION SCHEDULE; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN SUBUNITS;

EID: 0035983492     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1730457     Document Type: Article

References (58)

1. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase
2. Function and activation of NF-κB in the immune system
3. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
4. Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis
5. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes
6. Interleukin-12
7. Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis
8. Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays
9. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases
10. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans
11. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages
12. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages
13. 6-alkylating ability
14. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
15. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin
16. Cytokines activate the nuclear factor κ B (NF-κB) and induce nitric oxide production in human pancreatic islets
17. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes
18. Nitric oxide synthase: Expression and expressional control of the three isoforms
19. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
20. Maintenance of human normal cells and tumour cells in continuous culture
21. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
22. Protection of human islets from the effects of interleukin-1 beta by adenoviral gene transfer of an iκB repressor
23. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist
24. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice
25. Superoxide dismutase is a prophylactic against alloxan diabetes
26. 15N] nitrate in biological fluids
27. Interleukin-1β effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans - Arginine-dependence and relationship to insulin secretion
28. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: Regulation of T helper 1/T helper 2 responses
29. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents beta-cell apoptosis
30. Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: Roles of NF-κB in the activation and differentiation of autoreactive T cells
31. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB
32. Phosphorylation meets ubiquitination: The control of NF-[κ]B activity
33. Beta-cell activity and destruction in type 1 diabetes
34. Mouse models of insulin dependent diabetes: Low-dose streptozotocin-induced diabetes and nonobese diabetic (NOD) mice
35. IDDM: Lessons from the low-dose streptozotocin model in mice
36. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus
37. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies
38. Insulin-like growth factor I reverses interleukin-1 beta inhibition of insulin secretion, induction of nitric oxide synthase and cytokine-mediated apoptosis in rat islets of Langerhans
39. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer
40. Principles of Laboratory Animal Care
41. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice
42. Contribution of ductal cells to cytokine responses by human pancreatic islets
43. Administration of NF-κB decoy inhibits pancreatic activation of NF-κB and prevents diabetogenesis by alloxan in mice
44. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus
45. Complete protection from low-dose streptozotocin-induced diabetes in mice
46. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2
47. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells
48. Targeted; disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
49. Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-alpha by an L-arginine-dependent nitric oxide generating mechanism
50. Endothelial cells as cytotoxic effector cells: Cytokine-activated rat islet endothelial cells lyse syngeneic islet cells via nitric oxide
51. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice
52. NF-κB: A key role in inflammatory diseases
53. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy
54. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
55. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets
56. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice
57. Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-γ plus tumor necrosis factor-α
58. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells